Barriers, potential solutions, and alternatives to randomized clinical trials in male reproductive medicine
The field of reproductive medicine is enjoying a renaissance in advancement and innovation, as the evolution of laboratory techniques, genetic medicine, and assisted reproductive technologies (ART) have dramatically enhanced the quality of care and outcomes for patients with subfertility. From microfluidics to home semen testing, invention has rendered this an exciting time in the study of male reproductive medicine. Yet as pioneers continue to push the envelope, there remains an incomplete trail of evidence, hampering our ability to utilize these advancements in a way that will optimally serve our patients.
Source: fertstert.org
Barriers, potential solutions, and alternatives to randomized clinical trials in male reproductive medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment